Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
CryoPort Inc (NASDAQ: CYRX) closed the day trading at $8.49 up 4.94% from the previous closing price of $8.09. In other words, the price has increased by $4.94 from its previous closing price. On the day, 0.9 million shares were traded. CYRX stock price reached its highest trading level at $8.62 during the session, while it also had its lowest trading level at $7.69.
Ratios:
For a better understanding of CYRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.47 and its Current Ratio is at 16.24. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.44.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 22 ’25 when Mandalam Ramkumar sold 40,728 shares for $7.24 per share. The transaction valued at 294,899 led to the insider holds 92,328 shares of the business.
RAMKUMAR MANDALAM bought 40,728 shares of CYRX for $273,285 on Jul 22 ’25. On Jun 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 16,344 shares for $7.06 each. As a result, the insider received 115,366 and left with 912,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 425664832 and an Enterprise Value of 229230880. As of this moment, CryoPort’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.10 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at 0.964 whereas that against EBITDA is -10.104.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.62, which has changed by 0.03536582 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $9.66, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is 17.22%, while the 200-Day Moving Average is calculated to be 22.58%.
Shares Statistics:
Over the past 3-months, CYRX traded about 671.73K shares per day on average, while over the past 10 days, CYRX traded about 1649860 shares per day. A total of 50.28M shares are outstanding, with a floating share count of 47.89M. Insiders hold about 4.48% of the company’s shares, while institutions hold 90.09% stake in the company. Shares short for CYRX as of 1753920000 were 2905756 with a Short Ratio of 4.33, compared to 1751241600 on 2755104. Therefore, it implies a Short% of Shares Outstanding of 2905756 and a Short% of Float of 6.9.
Earnings Estimates
The stock of CryoPort Inc (CYRX) is currently in the spotlight, with 4.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.16 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.84 and -$0.89 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.62, with 4.0 analysts recommending between -$0.46 and -$0.69.
Revenue Estimates
9 analysts predict $41.12M in revenue for the current quarter. It ranges from a high estimate of $42.42M to a low estimate of $39.3M. As of the current estimate, CryoPort Inc’s year-ago sales were $56.66MFor the next quarter, 9 analysts are estimating revenue of $43.29M. There is a high estimate of $44.11M for the next quarter, whereas the lowest estimate is $41.7M.
A total of 9 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $172.68M, while the lowest revenue estimate was $167.5M, resulting in an average revenue estimate of $170.91M. In the same quarter a year ago, actual revenue was $228.38MBased on 9 analysts’ estimates, the company’s revenue will be $185.86M in the next fiscal year. The high estimate is $198.08M and the low estimate is $180M.
